MiƱoza, Baby Boy -.
HRN: 24-87-95 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/16/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/16/2024
04/23/2024
IV
40mg
Q24H
Neonatal Sepsis
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes